Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
02/2007
02/01/2007US20070026017 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof
02/01/2007US20070026015 Method
02/01/2007US20070026002 treatment of mammals susceptible to or diagnosed with cancer, or with relapse tumor growth or relapse cancer cell growth
02/01/2007US20070025998 Methods for enhancing the efficacy of cancer therapy
02/01/2007US20070025996 Oculospanin as a tumor specific antigen and methods and compositions utilizing same
02/01/2007US20070025981 Microorganisms for therapy
02/01/2007US20070025975 Oligodendrocyte determination genes and uses thereof
02/01/2007US20070025974 Amylases producing an altered immunogenic response and methods of making and using the same
02/01/2007US20070025971 Substances causing differentiation
02/01/2007US20070025970 Vector system
02/01/2007US20070025969 RNAi expression constructs
02/01/2007US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes
02/01/2007US20070025967 Zap protein and related compositions and methods
02/01/2007US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies
02/01/2007DE102005035568A1 Frizzled 9 als Biomarker für Substrukturen des humanen Gehirns Frizzled 9 as a biomarker for substructures of the human brain
02/01/2007DE10141443B4 Verwendung von molekularbiologisch hergestellten, nicht-viralen Wirkstoffen zur Behandlung der Akne Using molecular biological manufactured, non-viral agents for the treatment of acne
02/01/2007CA2616877A1 Systems and methods for manufacturing liposomes
02/01/2007CA2616209A1 Tandem cardiac pacemaker system
02/01/2007CA2607668A1 Rnai modulation of the rho-a gene and uses thereof
01/2007
01/31/2007EP1748075A1 Recombinant chemokine-antigen vaccine
01/31/2007EP1748069A1 Follistatin mutant polypeptide
01/31/2007EP1748046A2 Inhibitors of histone deacetylase
01/31/2007EP1747462A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
01/31/2007EP1747277A1 Method for gene delivery to neuronal cells
01/31/2007EP1747226A1 Pharmaceuticals for enhanced deliver to disease targets
01/31/2007EP1747024A2 Dna virus microrna and methods for inhibiting same
01/31/2007EP1747023A2 Methods and compositions for reducing viral genome amounts in a target cell
01/31/2007EP1747022A2 INHIBITION OF HAIRLESS PROTEIN mRNA
01/31/2007EP1392838B1 Pseudotyping of hiv vectors with mokola virus envelopes
01/31/2007EP0804574B1 Human kappa opioid receptor, nucleic acids and uses thereof
01/31/2007CN1906302A Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS
01/31/2007CN1906301A HIV-1 Indian subtype C vaccine constructs for use in humans
01/31/2007CN1906297A IL-23 and its receptor, related reagents and methods
01/31/2007CN1906205A Reduction of dermal scarring
01/31/2007CN1906162A Hydroxy piperidine derivatives to treat gaucher disease
01/31/2007CN1904900A Human autogenous siRNA sequence, its application and screening method
01/31/2007CN1904056A Recombinant adeno-associated virus comprising VEGFR Truncated Soluble cDNA and gene therapeutic agent comprising the same
01/31/2007CN1904055A Targeted liposome gene delivery
01/31/2007CN1904054A Poultry infectivity bronchitis DNA vaccine pIBM and application
01/31/2007CN1904046A Single chain deoxynucleotide of anti human immune deficiency virus
01/31/2007CN1903877A Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application
01/31/2007CN1903876A Polypeptide, nucleic acid molecule coding it and use
01/31/2007CN1903870A Single chain DNA having therapeutic action against virus infection disease
01/31/2007CN1903373A Application of expression TRAIL protein colon bacillus for preparing medicine to treat tumor
01/31/2007CN1903372A Three gene combination DNA vaccine for avian infectious bronchitis, and application thereof
01/31/2007CN1903371A DNA vaccine pIBN for avian infectious bronchitis, and application thereof
01/31/2007CN1903370A DNA vaccine pIBS1 for avian infectious bronchitis and application thereof
01/31/2007CN1903363A Mosaic type virus-like particle DNA vaccine
01/31/2007CN1297320C Hair follicle-reconstitution system and animal carrying the same
01/30/2007US7169917 Purification of plasmid DNA by hydrophobic interaction chromatography
01/30/2007US7169904 Immunocytokine sequences and uses thereof
01/30/2007US7169898 Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
01/30/2007US7169758 Use of hepcidin as a regulator of iron homeostasis
01/30/2007US7169605 Methods of controlling proliferation and differentiation of stem and progenitor cells
01/30/2007US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo
01/30/2007US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA
01/30/2007US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets
01/30/2007US7169384 Gene for which is located on the short arm of human chromosome 1; gene is directly implicated in colon, kidney and breast cancers
01/30/2007CA2284859C Nucleic acid molecule for a human skeletal muscle-specific receptor
01/30/2007CA2167693C Melanoma-inhibiting protein
01/30/2007CA2166973C Immortalized human fetal osteoblastic cells
01/30/2007CA2107537C Inhibition of tumor cell growth by administration of b7-transfected cells
01/25/2007WO2007010999A1 Animal in which lipid metabolism and sugar metabolism are modified by krap gene mutation, modification method and modifying agent
01/25/2007WO2007010853A1 Method for control of electroporation apparatus
01/25/2007WO2007010840A1 MULTIPLE shRNA EXPRESSION VECTOR
01/25/2007WO2007010628A1 Prophylactic/therapeutic agent for cancer
01/25/2007WO2006105279A9 Defective sindbis viral vectors
01/25/2007WO2006085226A3 Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by insulin-like growth factor binding protein-3 (igfbp-3)
01/25/2007WO2006071200A3 Chinese hamster apoptosis-related genes
01/25/2007WO2006060680A3 Mda-7 protein variants having antiproliferative activity
01/25/2007WO2005118824A8 Methods and compositions for the inhibition of gene expression
01/25/2007WO2004063342A3 Cellular delivery and activation polypeptide-nucleic acid complexes
01/25/2007US20070021589 Obesity-related genes
01/25/2007US20070021375 Genetic modification of targeted regions of the cardiac conduction system
01/25/2007US20070021374 polypeptides derived from Streptococcus pneumoniae including surface or secreted proteins or parts thereof, that are useful as molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; vaccines
01/25/2007US20070021373 Administering polypeptide which elicits an immune response
01/25/2007US20070021372 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
01/25/2007US20070021371 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
01/25/2007US20070021370 Administering polypeptide which elicits immune response; antibodies useful as probes for detection; vaccines
01/25/2007US20070021369 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
01/25/2007US20070021368 Administering polypeptide to elicit immune response; pneumonia, otitis media; biodrugs
01/25/2007US20070021367 Modulation of SOCS-3 expression
01/25/2007US20070021366 Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
01/25/2007US20070021365 Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto
01/25/2007US20070021364 Methods for genetic immunization
01/25/2007US20070021363 Genomic replacement therapy
01/25/2007US20070021362 Antisense antibacterial method and compound
01/25/2007US20070021361 Methods and materials for modulating trpm2
01/25/2007US20070021360 Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase
01/25/2007US20070021337 Novel agent for inducing apoptosis comprising Msx1 or a gene encoding the same as an active ingredient
01/25/2007US20070021327 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
01/25/2007US20070021323 Use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
01/25/2007US20070020761 Solid surface for biomolecule delivery and high-throughput assay
01/25/2007US20070020730 Method for overexpression of zwitterionic polysaccharides
01/25/2007US20070020679 Modulation of HIF1alpha and HIF2alpha expression
01/25/2007US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease
01/25/2007US20070020666 Differentially expressed genes in large granular lymphocyte leukemia
01/25/2007US20070020635 Nucleotides for prevention and treatment of bacterial and fungal pathologies
01/25/2007US20070020632 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna)
01/25/2007US20070020630 Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-proliferative agents